Literature DB >> 29250725

Angelman Syndrome Due to UBE3A Gene Mutation.

Jyotindra Narayan Goswami1, Jitendra Kumar Sahu1, Pratibha Singhi2.   

Abstract

A 12-y-old boy presented with developmental delay, autism, epilepsy, limb tremors and behavioral problems which posed a diagnostic challenge. Though his clinical profile and electroencephalogram were suggestive of Angelman syndrome, initial genetic tests were unyielding. Exome sequencing revealed a previously unreported mutation of Ubiquitin Protein Ligase E3A (UBE3A) gene, confirming the diagnosis of Angelman syndrome. The case is aimed to sensitize pediatricians about Angelman syndrome and to highlight the role of sequential investigations in establishing the diagnosis.

Entities:  

Keywords:  Angelman syndrome; Happy Puppet syndrome; UBE3A; Ubiquitin Protein Ligase E3A

Mesh:

Substances:

Year:  2017        PMID: 29250725     DOI: 10.1007/s12098-017-2559-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  7 in total

1.  Angelman syndrome 2005: updated consensus for diagnostic criteria.

Authors:  Charles A Williams; Arthur L Beaudet; Jill Clayton-Smith; Joan H Knoll; Martin Kyllerman; Laura A Laan; R Ellen Magenis; Ann Moncla; Albert A Schinzel; Jane A Summers; Joseph Wagstaff
Journal:  Am J Med Genet A       Date:  2006-03-01       Impact factor: 2.802

Review 2.  Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes.

Authors:  Louisa Kalsner; Stormy J Chamberlain
Journal:  Pediatr Clin North Am       Date:  2015-04-22       Impact factor: 3.278

3.  UBE3A/E6-AP mutations cause Angelman syndrome.

Authors:  T Kishino; M Lalande; J Wagstaff
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

Review 4.  Autism spectrum disorders in Prader-Willi and Angelman syndromes: a systematic review.

Authors:  Marijcke W M Veltman; Ellen E Craig; Patrick F Bolton
Journal:  Psychiatr Genet       Date:  2005-12       Impact factor: 2.458

5.  Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects.

Authors:  Monica Castro Varela; Fernando Kok; Paulo Alberto Otto; Celia Priszkulnik Koiffmann
Journal:  Eur J Hum Genet       Date:  2004-12       Impact factor: 4.246

Review 6.  Angelman syndrome: a review of the clinical and genetic aspects.

Authors:  J Clayton-Smith; L Laan
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

7.  Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.

Authors:  Linyan Meng; Amanda J Ward; Seung Chun; C Frank Bennett; Arthur L Beaudet; Frank Rigo
Journal:  Nature       Date:  2014-12-01       Impact factor: 49.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.